Revised SPC: Duavive (oestrogens, conjugated/bazedoxifene acetate) modified release tablets

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
15 November 2019

Abstract

The SPC warns of a 2 to 4-fold increase in the risk of gallbladder disease requiring surgery in postmenopausal women receiving oestrogens; patients should therefore be monitored carefully for signs of development of gallbladder disease.